The Netherlands-based VRelax offers a science-backed VR application designed to help individuals self-manage their stress levels. It provides a scientifically validated solution for relaxation, addressing issues such as stress, burnout, anxiety, and gloom. The app offers immersive virtual nature environments, allowing users to experience calming natural settings and engage in interactive exercises for relaxation. VRelax can be used as a distraction tool for pain relief and physical discomfort as well as during medical procedures.
The company offers various packages tailored to different user needs, including options for healthcare professionals and organizations. VRelax is available as an annual subscription service, with pricing ranging from EUR 1,195 to EUR 1,593 per annum (~USD 1,300–1,730).
VRelax is also working on making its application available to consumers at an affordable price, alongside the addition of stress measurement features (via biofeedback).
Key customers and partnerships
As of May 2024, VRelax was used by over 200 mental health institutions across Europe and the US. Notable enterprises using the platform included the University Medical Center Groningen (UMCG) and the North Holland Police Control Room.
Funding and financials
In May 2024, the company raised EUR 1.2 million (~USD 1.3 million) in a venture round led by Healthy.Capital. The funds were earmarked to augment the company's growth in its domestic market while facilitating global expansion. Further, the funds were also to be used to expand VRelax’s sales and customer success teams.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.